Arca
Skip to content
Tools
Tools

Bilicocoon™ Phototherapy System

Unit, Neonatal Phototherapy. 510(k) K163526, from Neomedlight (Villeurbanne, FR). Product code LBI, class 2.

As of Nov 18, 2026, K163526 is an FDA 510(k) held by Neomedlight, substantially equivalent on Oct 6, 2017 after 294 days, with no recalls tied to it in FDA's recall database.

  • Review time: 294 days
  • Recalls: 0

Indications for use

As the 510(k) summary states them, read from FDA's summary PDF

The BiliCocoon™ Phototherapy System is intended for the treatment of unconjugated hyperbilirubinemia in the population of neonates and infants under 3 months old and weighing less than 10kg. It can be used in the clinical setting or in the home

Predicate devices

The legally marketed devices this 510(k) summary says it is substantially equivalent to, read from FDA's summary PDF

Other LBI clearances

The newest 510(k)s for the same product code; their median review was 211 days; see every LBI device

Record

Type
Traditional
Received
Dec 16, 2016
Review panel
General Hospital
Regulation
21 CFR 880.5700

One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.